Hologic (NSDQ:HOLX) released its 4th quarter earnings Wednesday, topping the street’s expectations on revenue and earnings per share while seeing losses shrink, and released its fiscal year 2016 outlook.
Hologic reported profits of $25.2 million, or 9¢ per share, on sales of $702.8 million for the 3 months ended September 30.
That amounts to a 10.6% slide on the bottom-line with sales growth of 6.4% compared with the same period last year.
Adjusted to exclude 1-time items, earnings per share were 43¢, beating Wall Street analysts expectations of 42¢ per share.
The company also handily beat the Street’s revenue expectations of $690.5 million.
Shares lifted slightly after the release, rising 1.3% to close at $39.96 yesterday.
“Hologic’s strong 4th quarter financial results capped off an outstanding year in which our people and our products enabled us to exceed expectations across the board. In the 4th quarter, revenue again increased at a double-digit rate on a constant currency basis excluding the 1-time Roka benefit, while earnings per share grew even faster. And importantly, all 4 of our primary businesses grew in the United States and Internationally on a constant currency basis,” CEO Steve MacMillan said in a press release.
Hologic set out guidance for the next quarter and year, with revenue up as high as 5% from last year and EPS up between 8 to 10%.
The company set its revenue outlook between $2.81 and $2.84 billion, and non-GAAP EPS between $1.80 and $1.84 for 2016. For the 1st quarter, Hologic expects to see revenue in the $680 to $690 million range and an EPS between 41¢ and 42¢.
“We are very pleased with our financial performance and prospects as we begin fiscal 2016. Building on our exceptional performance last year, we anticipate revenues in 2016 to grow at a mid-single-digit rate on a constant currency basis, with earnings per share increasing at roughly double that pace,” CFO Bob McMahon said in a press release